{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:59:09Z","timestamp":1790258349301,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","jpedsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric Surgery"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jpedsurg.2017.01.059","type":"journal-article","created":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T09:15:35Z","timestamp":1486026935000},"page":"1496-1502","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Inflammation factors in hepatoblastoma and their clinical significance as diagnostic and prognostic biomarkers"],"prefix":"10.1016","volume":"52","author":[{"given":"Fei","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Ru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiekai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpedsurg.2017.01.059_bb0005","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.jpedsurg.2016.02.091","article-title":"Combined low miR-34s are associated with unfavorable prognosis in children with hepatoblastoma: a Chinese population-based study","volume":"51","author":"Jiao","year":"2016","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.jpedsurg.2017.01.059_bb0010","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/petr.12699","article-title":"Effects of an early referral system on liver transplantation for hepatoblastoma at Texas Children's Hospital","volume":"20","author":"Kueht","year":"2016","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jpedsurg.2017.01.059_bb0015","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.canlet.2016.02.051","article-title":"Multidisciplinary effort in treating children with hepatoblastoma in China","volume":"375","author":"Yuan","year":"2016","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jpedsurg.2017.01.059_bb0020","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1002\/cncr.24609","article-title":"Serum macrophage migration-inhibitory factor as a diagnostic and prognostic biomarker for gastric cancer","volume":"115","author":"Xia","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.jpedsurg.2017.01.059_bb0025","doi-asserted-by":"crossref","first-page":"11689","DOI":"10.1038\/srep11689","article-title":"Low-molecular-mass secretome profiling identifies HMGA2 and MIF as prognostic biomarkers for oral cavity squamous cell carcinoma","volume":"5","author":"Chang","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.jpedsurg.2017.01.059_bb0030","doi-asserted-by":"crossref","first-page":"938","DOI":"10.7150\/jca.12286","article-title":"Role of chemokines in non-small cell lung cancer: angiogenesis and inflammation","volume":"6","author":"Rivas-Fuentes","year":"2015","journal-title":"J Cancer"},{"key":"10.1016\/j.jpedsurg.2017.01.059_bb0035","doi-asserted-by":"crossref","first-page":"e166067","DOI":"10.1371\/journal.pone.0166067","article-title":"Immunohistochemical typing of adenocarcinomas of the pancreatobiliary system improves diagnosis and prognostic stratification","volume":"11","author":"Fern\u00e1ndez Moro","year":"2016","journal-title":"PLos ONE"},{"key":"10.1016\/j.jpedsurg.2017.01.059_bb0040","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-016-0840-x","article-title":"Differential expression of the epigenetic methylation-related protein DNMT1 by breast cancer molecular subtype and stromal histology","volume":"14","author":"Shin","year":"2016","journal-title":"J Transl Med"},{"key":"10.1016\/j.jpedsurg.2017.01.059_bb0045","doi-asserted-by":"crossref","DOI":"10.1186\/s13000-016-0477-3","article-title":"Immunohistochemical and molecular detection of the expression of FGF23 in phosphaturic mesenchymal tumors including the non-phosphaturic variant","volume":"11","author":"Shiba","year":"2016","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.jpedsurg.2017.01.059_bb0050","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.ejca.2012.10.003","article-title":"Relapses in hepatoblastoma patients: clinical characteristics and outcome\u2014experience of the International Childhood Liver Tumour Strategy Group (SIOPEL)","volume":"49","author":"Semeraro","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jpedsurg.2017.01.059_bb0055","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/j.jpedsurg.2016.09.038","article-title":"Resectability and tumor response after preoperative chemotherapy in hepatoblastoma treated by the Japanese Study Group for Pediatric Liver Tumor (JPLT)-2 protocol","volume":"51","author":"Hiyama","year":"2016","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.jpedsurg.2017.01.059_bb0060","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejca.2015.09.023","article-title":"The Children's Hepatic Tumors International Collaboration (CHIC): novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model","volume":"52","author":"Czauderna","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jpedsurg.2017.01.059_bb0065","article-title":"Macrophage migration inhibitory factor: a potential driver and biomarker for head and neck squamous cell carcinoma","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jpedsurg.2017.01.059_bb0070","doi-asserted-by":"crossref","first-page":"e33752","DOI":"10.1371\/journal.pone.0033752","article-title":"PTRF\/Cavin-1 and MIF proteins are identified as non-small cell lung cancer biomarkers by label-free proteomics","volume":"7","author":"G\u00e1mez-Pozo","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jpedsurg.2017.01.059_bb0075","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1358\/dnp.2010.23.4.1453629","article-title":"Macrophage migration inhibitory factor (MIF): a promising biomarker","volume":"23","author":"Grieb","year":"2010","journal-title":"Drug News Perspect"},{"key":"10.1016\/j.jpedsurg.2017.01.059_bb0080","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1158\/0008-5472.CAN-15-1011","article-title":"MIF maintains the tumorigenic capacity of brain tumor-initiating cells by directly inhibiting p53","volume":"76","author":"Fukaya","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.jpedsurg.2017.01.059_bb0085","doi-asserted-by":"crossref","first-page":"8730","DOI":"10.4049\/jimmunol.177.12.8730","article-title":"Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells","volume":"177","author":"Meyer-Siegler","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jpedsurg.2017.01.059_bb0090","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.canlet.2016.02.005","article-title":"Macrophage migration inhibitory factor promotes breast cancer metastasis via activation of HMGB1\/TLR4\/NF kappa B axis","volume":"375","author":"Lv","year":"2016","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jpedsurg.2017.01.059_bb0095","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.11970","article-title":"Oxidized macrophage migration inhibitory factor is a potential new tissue marker and drug target in cancer","author":"Schinagl","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jpedsurg.2017.01.059_bb0100","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.drudis.2012.12.013","article-title":"Current developments of macrophage migration inhibitory factor (MIF) inhibitors","volume":"18","author":"Xu","year":"2013","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jpedsurg.2017.01.059_bb0105","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cytogfr.2015.03.002","article-title":"Macrophage migration inhibitory factor: a key cytokine and therapeutic target in colon cancer","volume":"26","author":"Gordon-Weeks","year":"2015","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jpedsurg.2017.01.059_bb0110","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1161\/ATVBAHA.108.169417","article-title":"Gleissner PVHA: platelet chemokines in vascular disease","volume":"28","author":"Christian","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jpedsurg.2017.01.059_bb0115","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1073\/pnas.0610330104","article-title":"SDGU: serum proteome profiling detects myelodysplastic syndromes and identifies CXC chemokine ligands 4 and 7 as markers for advanced disease","volume":"104","author":"Aivado","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jpedsurg.2017.01.059_bb0120","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1158\/0008-5472.CAN-13-1267","article-title":"The CXCL7\/CXCR1\/2 axis is a key driver in the growth of clear cell renal cell carcinoma","volume":"74","author":"Grepin","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.jpedsurg.2017.01.059_bb0125","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.amjsurg.2008.08.001","article-title":"Increased invasion through basement membrane by CXCL7-transfected breast cells","volume":"196","author":"Tang","year":"2008","journal-title":"Am J Surg"},{"key":"10.1016\/j.jpedsurg.2017.01.059_bb0130","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/cas.12603","article-title":"Overexpression of chemokine receptor CXCR2 and ligand CXCL7 in liver metastases from colon cancer is correlated to shorter disease-free and overall survival","volume":"106","author":"Desurmont","year":"2015","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jpedsurg.2017.01.059_bb0135","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.stemcr.2015.07.013","article-title":"Interleukin-25 mediates transcriptional control of PD-L1 via STAT3 in multipotent human mesenchymal stromal cells (hMSCs) to suppress Th17 responses","volume":"5","author":"Wang","year":"2015","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.jpedsurg.2017.01.059_bb0140","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.cytogfr.2010.10.002","article-title":"IL-17 family member cytokines: regulation and function in innate immunity","volume":"21","author":"Reynolds","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jpedsurg.2017.01.059_bb0145","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2217\/imt.15.36","article-title":"IL-25 as a potential therapeutic target in allergic asthma","volume":"7","author":"Knolle","year":"2015","journal-title":"Immunotherapy"},{"key":"10.1016\/j.jpedsurg.2017.01.059_bb0150","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1164\/rccm.201403-0505OC","article-title":"Epithelial interleukin-25 is a key mediator in Th2-high, corticosteroid-responsive asthma","volume":"190","author":"Cheng","year":"2014","journal-title":"Am J Resp Crit Care"},{"key":"10.1016\/j.jpedsurg.2017.01.059_bb0155","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1182\/blood-2007-09-112128","article-title":"Proteomics analysis of Hodgkin lymphoma: identification of new players involved in the cross-talk between HRS cells and infiltrating lymphocytes","volume":"111","author":"Ma","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jpedsurg.2017.01.059_bb0160","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1177\/014556131309200112","article-title":"Primary mucosal melanoma arising from the eustachian tube with CTLA-4, IL-17A, IL-17C, and IL-17E upregulation","volume":"92","author":"Wei","year":"2013","journal-title":"Ear Nose Throat J"}],"container-title":["Journal of Pediatric Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022346817300921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022346817300921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T01:52:54Z","timestamp":1568771574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022346817300921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0022346817300921"],"URL":"https:\/\/doi.org\/10.1016\/j.jpedsurg.2017.01.059","relation":{},"ISSN":["0022-3468"],"issn-type":[{"value":"0022-3468","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammation factors in hepatoblastoma and their clinical significance as diagnostic and prognostic biomarkers","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpedsurg.2017.01.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}